Crestchem FY26 results: 15 percent dividend, new Oleo Biosciences subsidiary
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Crestchem board approved audited FY26 results and recommended Rs 1.50 per share final dividend (15 percent) for shareholder approval. Profit for the year rose to Rs 375.74 lakh from Rs 365.68 lakh. Total assets grew to Rs 1,628.92 lakh from Rs 1,054.48 lakh. New subsidiary Oleo Biosciences (75 percent holding) was formed in Bangalore, with up to Rs 2.25 crore investment approved. Auditor gave a clean (unqualified) opinion on both standalone and consolidated results.
Positive signals: dividend payout, strong asset growth, and clean audit. New subsidiary is not yet operational, so near term impact on earnings is limited.